Niclas Norgren

Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden.

SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden.